Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$269,208
+$51,657 QoQ
Shares Held
1,060
+19.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#4,271
of 4,676 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cairn Investment Group, Inc. holds $15,565,541 across 7 Drug Manufacturers - General names. JNJ ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
54,875 | $7,051,437 | |
| 2 | LLY |
ELI LILLY & Co
|
2,610 | $3,130,512 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
21,247 | $2,684,345 | |
| 4 | BIIB |
Biogen Inc.
|
8,043 | $1,737,770 | |
| 5 | NVO |
Novo Nordisk A S
|
9,333 | $447,424 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
1,060 | $269,208 | |
| 7 | ABBV |
AbbVie Inc.
|
973 | $244,845 |
All Filings in JNJ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $269,208 | 1,060 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $217,551 | 890 | Shares | Sole | 2026-04-29 | |
| 2023-06-30 | $210,375 | 1,271 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $241,025 | 1,555 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $320,443 | 1,814 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $279,672 | 1,712 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $303,897 | 1,712 | Shares | Sole | 2022-07-28 | |
| 2021-03-31 | $267,890 | 1,630 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $236,070 | 1,500 | Shares | Sole | 2021-02-02 | |
| 2020-06-30 | $1,500,000 | 210,945 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||